Position in TMO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$30,672,703
+$21,011,681 QoQ
Shares Held
61,179
+211.3% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#369
of 2,606 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026J. Safra Sarasin Holding AG holds $98,829,762 across 8 Diagnostics & Research names. TMO ranks #2 (31.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
174,160 | $33,173,995 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
61,179 | $30,672,703 | |
| 3 | A |
Agilent Technologies, Inc.
|
229,477 | $30,481,426 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
4,666 | $2,456,367 | |
| 5 | NTRA |
Natera, Inc.
|
5,951 | $1,615,398 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,349 | $260,653 | |
| 7 | PSNL |
Personalis, Inc.
|
10,047 | $134,629 | |
| 8 | BIAF |
bioAffinity Technologies, Inc.
|
42,600 | $34,591 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,672,703 | 61,179 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $9,661,022 | 19,655 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $13,786,853 | 23,793 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $13,981,671 | 28,827 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $10,614,537 | 26,179 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $17,542,887 | 35,255 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $17,901,634 | 34,411 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,686,965 | 43,143 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $17,335,997 | 31,349 | Shares | Defined | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||